Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dan Hung Barouch, M.D.

Co-Author

This page shows the publications co-authored by Dan Barouch and Lisa Tostanoski.
Connection Strength

9.279
  1. Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters. NPJ Vaccines. 2022 Jan 10; 7(1):2.
    View in: PubMed
    Score: 0.980
  2. Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern. Sci Transl Med. 2021 Nov 03; 13(618):eabj3789.
    View in: PubMed
    Score: 0.968
  3. Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2. J Virol. 2021 11 09; 95(23):e0097421.
    View in: PubMed
    Score: 0.959
  4. Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2. bioRxiv. 2021 Jun 15.
    View in: PubMed
    Score: 0.942
  5. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters. Nat Med. 2020 11; 26(11):1694-1700.
    View in: PubMed
    Score: 0.893
  6. Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters. Med (N Y). 2022 Apr 08; 3(4):262-268.e4.
    View in: PubMed
    Score: 0.248
  7. SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaques. Sci Adv. 2022 Mar 18; 8(11):eabl6015.
    View in: PubMed
    Score: 0.248
  8. Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice. NPJ Vaccines. 2022 Feb 23; 7(1):23.
    View in: PubMed
    Score: 0.247
  9. Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants. Sci Transl Med. 2021 Nov 03; 13(618):eabj2641.
    View in: PubMed
    Score: 0.242
  10. A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primates. bioRxiv. 2021 Jul 14.
    View in: PubMed
    Score: 0.237
  11. Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera. J Virol. 2021 06 24; 95(14):e0040421.
    View in: PubMed
    Score: 0.236
  12. Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques. Nature. 2021 08; 596(7872):423-427.
    View in: PubMed
    Score: 0.236
  13. Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women. JAMA. 2021 06 15; 325(23):2370-2380.
    View in: PubMed
    Score: 0.236
  14. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. Nature. 2021 08; 596(7871):268-272.
    View in: PubMed
    Score: 0.235
  15. Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques. Cell. 2021 06 24; 184(13):3467-3473.e11.
    View in: PubMed
    Score: 0.235
  16. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. JAMA. 2021 04 20; 325(15):1535-1544.
    View in: PubMed
    Score: 0.233
  17. Novel approaches for vaccine development. Cell. 2021 03 18; 184(6):1589-1603.
    View in: PubMed
    Score: 0.232
  18. Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2021 Feb; 590(7844):E25.
    View in: PubMed
    Score: 0.230
  19. Low-Dose Ad26.COV2.S Protection Against SARS-CoV-2 Challenge in Rhesus Macaques. bioRxiv. 2021 Jan 27.
    View in: PubMed
    Score: 0.229
  20. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature. 2021 02; 590(7847):630-634.
    View in: PubMed
    Score: 0.227
  21. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2020 10; 586(7830):583-588.
    View in: PubMed
    Score: 0.222
  22. DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science. 2020 08 14; 369(6505):806-811.
    View in: PubMed
    Score: 0.219
  23. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020 08 14; 369(6505):812-817.
    View in: PubMed
    Score: 0.219
  24. Adenovirus Vector-Based Vaccines Confer Maternal-Fetal Protection against Zika Virus Challenge in Pregnant IFN-aßR-/- Mice. Cell Host Microbe. 2019 11 13; 26(5):591-600.e4.
    View in: PubMed
    Score: 0.210
  25. Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice. Proc Natl Acad Sci U S A. 2021 09 21; 118(38).
    View in: PubMed
    Score: 0.060
  26. Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters. bioRxiv. 2021 Mar 04.
    View in: PubMed
    Score: 0.058
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.